CLS1 — McKesson Europe AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge Cap

Annual income statement for McKesson Europe AG, fiscal year end - March 31st, EUR millions except per share, conversion factor applied.

	2018 March 31st	R2019 March 31st	2020 March 31st	R2021 March 31st	2022 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	21,090	16,417	17,118	8,518	9,257
Cost of Revenue
Gross Profit	2,126	1,851	1,878	753	799
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	21,375	16,414	17,126	8,505	9,303
Operating Profit	-285	2.7	-8.6	12.5	-46.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-304	1.9	-29.5	21.1	-35.1
Provision for Income Taxes
Net Income After Taxes	-299	-42.4	-66.1	6.2	-49.4
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-299	-59	-249	-10.7	-872
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-299	-59	-249	-10.7	-872
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.114	0.06	-0.03	0.262	0.076
Dividends per Share